1. |
Fusco F, Paciolla M, Conte MI, et al. Incontinentia pigmenti: report on data from 2000 to 2013[J/OL]. Orphanet J Rare Dis, 2014, 9: 93[2014-06-24]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083330/. DOI: 10.1186/1750-1172-9-93.
|
2. |
Poziomczyk CS, Recuero JK, Bringhenti L, et al. Incontinentia pigmenti[J]. An Bras Dermatol, 2014, 89(1): 26-36. DOI: 10.1590/abd1806-4841.20142584.
|
3. |
彭婕, 张琦, 龙新纯, 等. 色素失禁症的眼部表现及治疗[J]. 中华眼底病杂志, 2015, 31(3): 307-309. DOI: 10.3760/cma.j.issn.1005-1015.2015.03.028.Peng J, Zhang Q, Long XC, et al. Ocular manifestations and treatment of incontinentia pigmenti[J]. Chin J Ocul Fundus Dis, 2015, 31(3): 307-309. DOI: 10.3760/cma.j.issn.1005-1015.2015.03.028.
|
4. |
Liao SL, Lai SH, Huang JL, et al. Serial cytokine expressions in infants with incontinentia pigmenti[J]. Immunobiology, 2013, 218(5): 772-779. DOI: 10.1016/j.imbio.2012.08.280.
|
5. |
Holmström G, Thorén K. Ocular manifestations of incontinentia pigmenti[J]. Acta Ophthalmol Scand, 2000, 78(3): 348-353. DOI: 10.1034/j.1600-0420.2000.078003348.x.
|
6. |
Fusco F, Bardaro T, Fimiani G, et al. Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-kappaB activation[J]. Hum Mol Genet, 2004, 13(16): 1763-1773. DOI: 10.1093/hmg/ddh192.
|
7. |
Minić S, Obradović M, Kovacević I, et al. Ocular anomalies in incontinentia pigmenti: literature review and meta-analysis[J]. Srp Arh Celok Lek, 2010, 138(7-8): 408-413. DOI: 10.2298/sarh1008408m.
|
8. |
王雪, 梁建宏. 色素失禁症相关性视网膜病变5例的临床分析[J]. 中华眼科杂志, 2019, 55(4): 294-301. DOI: 10.3760/cma.j.issn.0412-4081.2019.04.012.Wang X, Liang JH. Treatment of retinopathy of incontinentia pigmenti by anti-vascular endothelial growth factor[J]. Chin J Ophthalmol, 2019, 55(4): 294-301. DOI: 10.3760/cma.j.issn.0412-4081.2019.04.012.
|
9. |
Landy SJ, Donnai D. Incontinentia pigmenti (Bloch-Sulzberger syndrome)[J]. J Med Genet, 1993, 30(1): 53-59. DOI: 10.1136/jmg.30.1.53.
|
10. |
李曼红, 张自峰, 王雨生. 色素失禁症[M]//王雨生. 图说小儿眼底病. 北京: 人民卫生出版社, 2018: 124-130. Li MH, Zhang ZF, Wang YS. Incontinentia pigmenti[M]//Wang YS. Illustrated essentials of pediatric vitreoretinal diseases. Beijing: People's Medical Publishing House, 2018: 124-130.
|
11. |
Goldberg MF, Custis PH. Retinal and other manifestations of incontinentia pigmenti (Bloch-Sulzberger syndrome)[J]. Ophthalmology, 1993, 100(11): 1645-1654. DOI: 10.1016/s0161-6420(93)31422-3.
|
12. |
Smahi A, Courtois G, Vabres P, et al. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium[J]. Nature, 2000, 405(6785): 466-472. DOI: 10.1038/35013114.
|
13. |
Minić S, Trpinac D, Obradović M. Incontinentia pigmenti diagnostic criteria update[J]. Clin Genet, 2014, 85(6): 536-542. DOI: 10.1111/cge.12223.
|
14. |
王亮, 李曼红, 张自峰, 等. 婴幼儿色素失禁症相关眼部病变的临床特征分析[J]. 中华实验眼科杂志, 2021, 39(1): 34-41. DOI: 10.3760/cma.j.cn11598920200624-00451.Wang L, Li MH, Zhang ZF, et al. Clinical features of ocular anomalies in infants with incontinentia pigmenti[J]. Chin J Exp Ophthalmol, 2021, 39(1): 34-41. DOI: 10.3760/cma.j.cn11598920200624-00451.
|
15. |
Peng J, Zhang Q, Long XC, et al. Incontinentia pigmenti-associated ocular anomalies of paediatric incontinentia pigmenti patients in China[J]. Acta Ophthalmol, 2019, 97(3): 265-272. DOI: 10.1111/aos.13781.
|
16. |
Swinney CC, Han DP, Karth PA. Incontinentia pigmenti: a comprehensive review and update[J]. Ophthalmic Surg Lasers Imaging Retina, 2015, 46(6): 650-657. DOI: 10.3928/23258160-20150610-09.
|
17. |
Yang Y, Guo Y, Ping Y, et al. Neonatal incontinentia pigmenti: six cases and a literature review[J]. Exp Ther Med, 2014, 8(6): 1797-1806. DOI: 10.3892/etm.2014.2011.
|
18. |
王琼, 丁小燕, 黄思建, 等. 色素失禁症相关视网膜病变12例患者临床分析[J]. 中华眼底病杂志, 2021, 37(4): 277-283. DOI: 10.3760/cma.j.cn51143420200826-00407.Wang Q, Ding XY, Huang SJ, et al. Clinical features and treatment of 12 cases with incontinentia pigmenti-associated retinopathy[J]. Chin J Ocul Fundus Dis, 2021, 37(4): 277-283. DOI: 10.3760/cma.j.cn51143420200826-00407.
|
19. |
Nakao S, Nishina S, Tanaka S, et al. Early laser photocoagulation for extensive retinal avascularity in infants with incontinentia pigmenti[J]. Jpn J Ophthalmol, 2020, 64(6): 613-620. DOI: 10.1007/s10384-020-00768-7.
|
20. |
Sanghi G, Dogra MR, Ray M, et al. Predominant exudative retinopathy in incontinentia pigmenti and clinical course after peripheral laser photocoagul-ation[J]. Indian J Ophthalmol, 2011, 59(3): 255-256. DOI: 10.4103/0301-4738.81022.
|
21. |
Cernichiaro-Espinosa LA, Patel NA, Bauer MS, et al. Revascularization after intravitreal bevacizumab and laser therapy of bilateral retinal vascular occlusions in incontinentia pigmenti (Bloch-Sulzberger syndrome)[J/OL]. Ophthalmic Surg Lasers Imaging Retina, 2019, 50(2): e33-e37[2015-02-01]. https://pubmed.ncbi.nlm.nih.gov/30768227/. DOI: 10.3928/ 23258160-20190129-16.
|
22. |
Narang S, Sindhu M, Jain S, et al. Retinal imaging in incontinentia pigmenti[J]. Indian J Ophthalmol, 2019, 67(6): 944-945. DOI: 10.4103/ijo.IJO_417_19.
|
23. |
Shah PK, Bachu S, Narendran V, et al. Intravitreal bevacizumab for incontinentia pigmenti[J/OL]. J Pediatr Ophthalmol Strabismus, 2013, 50: e52-e54[2013-10-29]. https://pubmed.ncbi.nlm.nih.gov/25313552/. DOI: 10.3928/01913913-20131022-01.
|